文献速递肿瘤 PET/CT心脏核医学神经核医学

人工智能优化与解读PET/CT及PET/MR图像

Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images.
PubMed 文献 · Semin Nucl Med · 2020-11-11

本文综述人工智能(AI)在PET/CT与PET/MRI优化和解读中的进展,涵盖PET重建与图像质量改进、基于MRI的衰减校正,以及全身肿瘤、心脏和神经等临床应用示例,并指出AI有望提升图像质量与安全性及纵向病灶随访解读能力。

要点

  • AI可用于改进PET重建与图像质量,潜在获益包括更快采集、更快重建及更低或「零」辐射剂量成像
  • AI驱动方法可用于基于MRI的衰减校正
  • AI有望用于全身肿瘤、心脏和神经等适应证的图像解读与病灶随访

核心结论

  • AI很可能显著提升PET/CT与PET/MRI的质量和安全性,并增强扫描解读与随时间随访病灶的能力,从而拓展临床用途、改善患者照护

研究设计与样本

  • 本文为综述,总结AI用于优化PET/CT与PET/MRI研究的进展,未报告检索范围与样本量

主要发现

  • PET与PET/MRI将分子信息与结构及功能成像结合,数据丰富,适合AI等数据驱动技术
  • AI用于改进PET重建和图像质量,可带来更快图像采集、图像重建以及更低或「零」辐射剂量成像等多重获益
  • 文章还讨论AI驱动方法用于基于MR的衰减校正的价值,并给出全身肿瘤、心脏和神经应用示例

临床怎么用

  • 可将AI用于PET重建与图像质量优化、MR-based衰减校正,以及全身肿瘤、心脏和神经适应证下的图像解读与病灶随访

局限性

  • 原文为综述性文章,未报告具体研究设计、样本量、效应量或统计阈值

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Artificial intelligence (AI) has recently attracted much attention for its potential use in healthcare applications. The use of AI to improve and extract more information out of medical images, given their parallels with natural images and the immense progress in the area of computer vision, has been at the forefront of these advances. This is due to a convergence of factors, including the increasing numbers of scans performed, the availability of open source AI tools, and decreases in the costs of hardware required to implement these technologies. In this article, we review the progress in the use of AI toward optimizing PET/CT and PET/MRI studies. These two methods, which combine molecular information with structural and (in the case of MRI) functional imaging, are extremely valuable for a wide range of clinical indications. They are also tremendously data-rich modalities and as such are highly amenable to data-driven technologies such as AI. The first half of the article will focus on methods to improve PET reconstruction and image quality, which has multiple benefits including faster image acquisition, image reconstruction, and lower or even "zero" radiation dose imaging. It will also address the value of AI-driven methods to perform MR-based attenuation correction. The second half will address how some of these advances can be used to perform to optimize diagnosis from the acquired images, with examples given for whole-body oncology, cardiology, and neurology indications. Overall, it is likely that the use of AI will markedly improve both the quality and safety of PET/CT and PET/MRI as well as enhance our ability to interpret the scans and follow lesions over time. This will hopefully lead to expanded clinical use cases for these valuable technologies leading to better patient care.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Zaharchuk G, Davidzon G. Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images. Semin Nucl Med. 2020. PMID: 33509370. doi:10.1053/j.semnuclmed.2020.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。